Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus [6]

Chest

Volumn 118, Issue 4, 2000, Pages 1229-1230

  Horn, E M ^a   Barst, R J ^a   Poon, M ^a  

^a NewYork Presbyterian Columbia University Irving Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISONE; PROSTACYCLIN; STEROID; VINCRISTINE;

COLLAGEN DISEASE; DISEASE PREDISPOSITION; DRUG EFFICACY; HUMAN; IMMUNOTHERAPY; LETTER; LONG TERM CARE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK BENEFIT ANALYSIS; SPLENECTOMY; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

EID: 0033790605     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.4.1229     Document Type: Letter

References (1)

1. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus